Return On Assets of NEXIEN BIOPHARMA, INC. from 30 Jun 2017 to 31 Mar 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
NEXIEN BIOPHARMA, INC. quarterly and annual Return On Assets in % history and change rate from 30 Jun 2017 to 31 Mar 2025.
  • NEXIEN BIOPHARMA, INC. Return On Assets for the quarter ending 31 Mar 2025 was -4017%, a 235% decline year-over-year.
  • NEXIEN BIOPHARMA, INC. annual Return On Assets for 2024 was -2218%, a 334% decline from 2023.
  • NEXIEN BIOPHARMA, INC. annual Return On Assets for 2023 was -511%, a 43% increase from 2022.
  • NEXIEN BIOPHARMA, INC. annual Return On Assets for 2022 was -898%, a 84% increase from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

NEXIEN BIOPHARMA, INC. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q1 2025 -4017% -2817% -235% 01 Jan 2025 31 Mar 2025
Q4 2024 -3418% -2552% -295% 01 Oct 2024 31 Dec 2024
Q3 2024 -3016% -2333% -342% 01 Jul 2024 30 Sep 2024
Q2 2024 -2218% -1707% -334% 01 Apr 2024 30 Jun 2024
Q1 2024 -1200% -799% -199% 01 Jan 2024 31 Mar 2024
Q4 2023 -866% -446% -106% 01 Oct 2023 31 Dec 2023
Q3 2023 -683% -46% -7.2% 01 Jul 2023 30 Sep 2023
Q2 2023 -511% +387% +43% 01 Apr 2023 30 Jun 2023
Q1 2023 -401% +1180% +75% 01 Jan 2023 31 Mar 2023
Q4 2022 -420% +1378% +77% 01 Oct 2022 31 Dec 2022
Q3 2022 -637% +2413% +79% 01 Jul 2022 30 Sep 2022
Q2 2022 -898% +4805% +84% 01 Apr 2022 30 Jun 2022
Q1 2022 -1581% +5788% +79% 01 Jan 2022 31 Mar 2022
Q4 2021 -1798% +4116% +70% 01 Oct 2021 31 Dec 2021
Q3 2021 -3050% +887% +23% 01 Jul 2021 30 Sep 2021
Q2 2021 -5704% -3534% -163% 01 Apr 2021 30 Jun 2021
Q1 2021 -7368% -5801% -370% 01 Jan 2021 31 Mar 2021
Q4 2020 -5914% -5074% -604% 01 Oct 2020 31 Dec 2020
Q3 2020 -3937% -3139% -394% 01 Jul 2020 30 Sep 2020
Q2 2020 -2170% -1586% -272% 01 Apr 2020 30 Jun 2020
Q1 2020 -1567% -1209% -337% 01 Jan 2020 31 Mar 2020
Q4 2019 -840% -538% -178% 01 Oct 2019 31 Dec 2019
Q3 2019 -797% -657% -469% 01 Jul 2019 30 Sep 2019
Q2 2019 -583% -442% -313% 01 Apr 2019 30 Jun 2019
Q1 2019 -358% -203% -131% 01 Jan 2019 31 Mar 2019
Q4 2018 -303% -95% -45% 01 Oct 2018 31 Dec 2018
Q3 2018 -140% +229% +62% 01 Jul 2018 30 Sep 2018
Q2 2018 -141% -1.7% -1.2% 01 Apr 2018 30 Jun 2018
Q1 2018 -155% 01 Jan 2018 31 Mar 2018
Q4 2017 -208% 01 Oct 2017 31 Dec 2017
Q3 2017 -369% 01 Jul 2017 30 Sep 2017
Q2 2017 -140% 27 Mar 2017 30 Jun 2017

NEXIEN BIOPHARMA, INC. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -2218% -1707% -334% 01 Jul 2023 30 Jun 2024
2023 -511% +387% +43% 01 Jul 2022 30 Jun 2023
2022 -898% +4805% +84% 01 Jul 2021 30 Jun 2022
2021 -5704% -3534% -163% 01 Jul 2020 30 Jun 2021
2020 -2170% -1586% -272% 01 Jul 2019 30 Jun 2020
2019 -583% -442% -313% 01 Jul 2018 30 Jun 2019
2018 -141% -130% -1162% 01 Jul 2017 30 Jun 2018
2017 -11% 01 Jul 2016 30 Jun 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.